Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.
about
Pharmacological validation of candidate causal sleep genes identified in an N2 crossMoving beyond energy homeostasis: new roles for glucagon-like peptide-1 in food and drug rewardGLP-1-based strategies: a physiological analysis of differential mode of actionA continued saga of Boc5, the first non-peptidic glucagon-like peptide-1 receptor agonist with in vivo activitiesGut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutidePeripheral signals mediate the beneficial effects of gastric surgery in obesityThe anorectic effect of GLP-1 in rats is nutrient dependentObesity: Current and potential pharmacotherapeutics and targets.Brain delivery of proteins via their fatty acid and block copolymer modificationsNeuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect.Liraglutide and obesity: a review of the data so far.Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas.Liraglutide administration in type 2 diabetic patients who either received no previous treatment or were treated with an oral hypoglycemic agent showed greater efficacy than that in patients switching from insulinGlucagon-like peptide-1 receptor activation in the nucleus accumbens core suppresses feeding by increasing glutamatergic AMPA/kainate signaling.Novel GLP-1 Analog Supaglutide Reduces HFD-Induced Obesity Associated with Increased Ucp-1 in White Adipose Tissue in Mice.The GLP-1 agonist exendin-4 attenuates self-administration of sweetened fat on fixed and progressive ratio schedules of reinforcement in rats.Gut hormones such as amylin and GLP-1 in the control of eating and energy expenditure.The role of gastrointestinal hormones in the pathogenesis of obesity and type 2 diabetes.Hindbrain nucleus tractus solitarius glucagon-like peptide-1 receptor signaling reduces appetitive and motivational aspects of feeding.Agile delivery of protein therapeutics to CNSRole of capsaicin-sensitive peripheral sensory neurons in anorexic responses to intravenous infusions of cholecystokinin, peptide YY-(3-36), and glucagon-like peptide-1 in ratsExpression and distribution of glucagon-like peptide-1 receptor mRNA, protein and binding in the male nonhuman primate (Macaca mulatta) brain.Liraglutide, leptin and their combined effects on feeding: additive intake reduction through common intracellular signalling mechanisms.GLP-1 based therapeutics: simultaneously combating T2DM and obesity.The gut sensor as regulator of body weight.The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1.Jejunal linoleic acid infusions require GLP-1 receptor signaling to inhibit food intake: implications for the effectiveness of Roux-en-Y gastric bypass.Glucagon-like peptide-1 receptor agonists suppress water intake independent of effects on food intake.Hippocampal GLP-1 receptors influence food intake, meal size, and effort-based responding for food through volume transmissionShort-term effects of liraglutide on visceral fat adiposity, appetite, and food preference: a pilot study of obese Japanese patients with type 2 diabetes.Incretins and amylin: neuroendocrine communication between the gut, pancreas, and brain in control of food intake and blood glucose.GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake.Mice Deficient in Proglucagon-Derived Peptides Exhibit Glucose Intolerance on a High-Fat Diet but Are Resistant to Obesity.Regulation of energy balance by a gut-brain axis and involvement of the gut microbiota.CCK Response Deficiency in Synphilin-1 Transgenic Mice.Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake.Exendin-4 decreases amphetamine-induced locomotor activity.Peripheral neural targets in obesityPlasticity of gastrointestinal vagal afferent satiety signals.Direct control of brown adipose tissue thermogenesis by central nervous system glucagon-like peptide-1 receptor signaling.
P2860
Q24623267-B7F167DE-CCB2-4132-BDAA-E6069D63E5B6Q26826926-334311C9-27C4-4749-B3A0-CA8F81697838Q26997149-4EF88534-89A3-4FDD-9342-252B4ED5ED72Q27027240-1012EC66-BC15-436C-AF4F-111BF207BA55Q28081671-4111FD23-B2C8-4D60-962B-BE322E343653Q28088425-FBC8AEDD-EB02-402A-87B3-35D3E58A8736Q28484398-AB12C184-AC86-42EA-AD08-0DAF03A5BDA4Q30243992-42B48068-F51E-4B44-A287-2DFC50CBE27CQ30354932-643B84D2-F76F-4E87-B5E5-9323FA294716Q30412673-1BDB36F6-593F-4E5D-AF83-F5E7EF8A81D3Q30924982-80809AF2-D6A2-40DA-A5DF-78408913BF6BQ33603384-EE57C91B-EEE8-4321-8425-CB4B592736CEQ33603478-B964918F-9CDE-47F6-80F0-8F8E4F6F82B0Q33605813-087202F7-35AA-4388-98CD-5ACB43101345Q33679277-950E3223-3BF2-47BF-B3BF-D3F4963AA4A0Q33787829-4CD7207B-4AE1-46B6-8311-FC3C499FED8FQ33838133-188351DB-CD23-4CD8-B7AC-3C9D60D1D8F5Q33941355-D86EC244-7E83-4AC6-ACD0-F5F22373CE37Q34062928-733F3F34-7BC1-4BB8-9D44-67CD6682FAFCQ34079647-B022B189-596C-4A7C-BDF8-A531C20543A9Q34356012-EE2C4A9A-B75C-491B-A7AD-83A7EC94053AQ34745109-AB8616D1-DB60-486E-A55D-09DABB69A0C2Q35060716-D2D917F1-9EEB-4316-AFF7-D969441E33ADQ35200252-36EB6BB2-F116-4223-B8FE-3D5CD06A8B84Q35535513-A2D6F715-CEC8-4DAD-9FC6-AA95F1563FABQ35543398-4C8731CF-1505-49DA-99B6-443E6307B5FAQ35601262-65233345-3331-4400-B628-B754A8C46FE4Q35601526-029DF886-3AE7-4DF8-8A54-2E3E98EC441DQ35647295-FEB4B93F-9FE0-4F53-BC17-F30F8470A8AFQ35677365-FEF307DC-25B3-4D4F-9661-6DD32A1416DCQ35690970-4DB83A31-3EB4-4877-85EF-51BEAECE6898Q35744558-B4880940-0A1E-4A1C-8E12-588E09D2855CQ35778163-6E146D29-E51B-4E91-B05B-EBC82FC4C200Q35834277-F50640C8-B1A8-4C3B-B222-3AD7E2D514ADQ35841627-97F98AA9-977F-47C1-901E-B742F6D31051Q35893496-69DEAA5E-DB63-4B40-83BB-F4D8E5561D27Q35948898-8E03F673-6937-472F-8B00-66E0E9108B13Q36166645-DF418EE9-2EFF-41E0-8635-F436A121A23AQ36174384-08D6FCA3-0715-4AB1-939F-A884C148234FQ36339639-EE7D270D-EE66-46A7-817F-15FF8C2D8A57
P2860
Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Peripheral and central GLP-1 r ...... ts, liraglutide and exendin-4.
@ast
Peripheral and central GLP-1 r ...... ts, liraglutide and exendin-4.
@en
type
label
Peripheral and central GLP-1 r ...... ts, liraglutide and exendin-4.
@ast
Peripheral and central GLP-1 r ...... ts, liraglutide and exendin-4.
@en
prefLabel
Peripheral and central GLP-1 r ...... ts, liraglutide and exendin-4.
@ast
Peripheral and central GLP-1 r ...... ts, liraglutide and exendin-4.
@en
P2093
P2860
P356
P1433
P1476
Peripheral and central GLP-1 r ...... ts, liraglutide and exendin-4.
@en
P2093
Harvey J Grill
Matthew R Hayes
Myrtha Arnold
Samantha M Fortin
Scott E Kanoski
P2860
P304
P356
10.1210/EN.2011-0174
P407
P577
2011-06-21T00:00:00Z